Theriva Biologics TOVX Q1 2025 earnings
Reported May 14, 2025 · Before market open
EPS-$1.55Beat by $2.64
EPS estimate-$4.19
Next report
Aug 12, 2026 (In 1 week)Revenue estimate$300.0K
EPS estimate-$0.06
Versus estimates
Diluted EPS
Ask the moment Theriva Biologics reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Theriva Biologics report Q1 2025 earnings?
- Theriva Biologics (TOVX) reported Q1 2025 earnings on May 14, 2025 before market open.
- What were Theriva Biologics's Q1 2025 revenue and EPS?
- Theriva Biologics reported eps of $-1.55 for Q1 2025.
- Did Theriva Biologics beat estimates in Q1 2025?
- EPS beat the consensus estimate of $-4.19 by $2.64.
- How did Theriva Biologics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 79.3% from $-7.50.
- Where can I find Theriva Biologics's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001410578-25-001242) directly on SEC EDGAR. The filing index links above go to sec.gov.